While Insulet Corporation has underperformed by -1.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PODD rose by 57.98%, with highs and lows ranging from $289.46 to $160.19, whereas the simple moving average jumped by 8.93% in the last 200 days.
On March 06, 2025, RBC Capital Mkts started tracking Insulet Corporation (NASDAQ: PODD) recommending Outperform. A report published by Bernstein on November 06, 2024, Initiated its previous ‘Outperform’ rating for PODD. Redburn Atlantic also rated PODD shares as ‘Buy’, setting a target price of $235 on the company’s shares in an initiating report dated May 30, 2024. Robert W. Baird December 21, 2023d its ‘Neutral’ rating to ‘Outperform’ for PODD, as published in its report on December 21, 2023. Morgan Stanley’s report from December 04, 2023 suggests a price prediction of $234 for PODD shares, giving the stock a ‘Overweight’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Insulet Corporation (PODD)
Further, the quarter-over-quarter increase in sales is 17.20%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Insulet Corporation’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 43.03% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.73, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 710.86K can be a very valuable indicator of volatility for PODD stock. On a monthly basis, the volatility of the stock is set at 3.79%, whereas on a weekly basis, it is put at 3.37%, with a loss of -1.93% over the past seven days. Furthermore, long-term investors anticipate a median target price of $324.38, showing growth from the present price of $260.27, which can serve as yet another indication of whether PODD is worth investing in or should be passed over.
How Do You Analyze Insulet Corporation Shares?
The USA based company Insulet Corporation (PODD) is one of the biggest names in Medical Devices. When comparing Insulet Corporation shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 44.96, there is a growth in quarterly earnings of -6.24%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.47%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 101.67% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PODD shares are owned by institutional investors to the tune of 101.67% at present.
